Monthly E-News Update
Alzheimer's Association
Having trouble reading this email?
View it in your browser
Forward Forward this message to a Friend
Recently, the Alzheimer's Association announced the launch of the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER), the first study of a multidimensional lifestyle intervention in a large-scale U.S.-based population. In this issue, we explore a potential new path for Alzheimer's disease treatments that has been opened by the FDA. Thanks to the support of organizations such as NARFE, the Association continues to see great progress in science, and with increased investments by the federal government in Alzheimer's and dementia research we are confident that progress will continue to accelerate. It is with this investment in research that we will gain understanding about the causes of Alzheimer's and other dementias, and discover targets for therapies. Thank you, NARFE members, for helping us lead the way.
FDA opens potential new path for Alzheimer's disease treatments
FDA opens potential new path for Alzheimer's disease treatments
The U.S. Food and Drug Administration (FDA) has issued draft guidance meant to spur the development of treatments for five neurological disorders, including early Alzheimer's disease. The guidance provides details for researchers to best approach drug development and "is a clear statement that the FDA understands that the science of Alzheimer's has evolved," said Maria Carrillo, Alzheimer's Association chief science officer. Learn more.
African-Americans are at a higher risk of developing Alzheimer's
African-Americans are at a higher risk of developing Alzheimer's
Older African-Americans are about twice as likely to have Alzheimer's disease and other dementias as older whites but less likely to receive an Alzheimer's diagnosis, which results in less time for treatment and planning. Visit our African-Americans and Alzheimer's website for information on warning signs, research and care. Learn more.
Hearing loss may raise the odds of developing dementia
Hearing loss may raise the odds of developing dementia
In a new study, researchers reviewed data from 36 studies including more than 20,000 people worldwide and found an association between age-related hearing loss and increased risk for mental impairment and dementia. The researchers stressed that this is not proof of a cause-and-effect relationship between hearing loss and cognitive decline, and they saw no relationship between hearing loss and Alzheimer's disease. Research results reported at the Alzheimer's Association International Conference® 2017 also provided clues about associations between cognitive status and hearing in older people. Learn more.

Online Tools
Alzheimer's Navigator
Caregiver Stress Check
Your Local Community
Find a chapter here
Join Our Mailing List
Sign Up

NARFE Contributions to Advance Alzheimer's Research

NARFE Contributions
Donate Today
24/7 Helpline: 1-800-272-3900
Your donation will strengthen our efforts to advance Alzheimer's care, support and research. From face-to-face support to online education programs and promising global research initiatives, your gift makes a difference in the lives of all those affected by Alzheimer's and other dementias in your community and across the world. Thank you for your continued support.

Alzheimer's Association National Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2018 Alzheimer's Association. All rights reserved.
800.272.3900 |® | Donate

View your email preferences or unsubscribe.